Good scientific principles and practices are essential for maintaining quality data that patients can benefit from.
Matthew Reaney
Advertisement
Senior Principal Scientist, Patient Centered Endpoints, IQVIA
Articles by Matthew Reaney
Applied Clinical Trials
Measuring clinically relevant response requires routine and regular collection of outcomes data.
Applied Clinical Trials
Combining PRO data with clinical feasibility data can make a difference in diabetes care.
Applied Clinical Trials
Type 2 diabetes mellitus is one of the Western world’s most common chronic conditions, with global prevalence increasing rapidly.
Applied Clinical Trials
Trulicity® (dulaglutide), approved by the EMA in November 2014 for the treatment of Type 2 diabetes in adults, is the first diabetes drug to have a Patient Reported Outcome.
Advertisement
Latest Updated Articles
Therapeutic Success or Failure: A Journey, Not Just a DestinationFebruary 1st 2016
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Achieving Clinical Trial Success with Three Key Elements of eCOA User Acceptance Testing
2
2026 DIA Global Annual Meeting: Why Protocol Digitization Has Been So Hard to Automate—Until Now
3
Tapping the Global Potential of China’s Biotech Surge
4
One Strategy, Two Jurisdictions: Unlocking Efficiency Across EU CTR and UK Regulatory Reform
5